As of April 16, 2025, Instil Bio (TIL) has a market cap of $0.11 billion USD. According to our data, Instil Bio is ranked No.7512 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.11 B |
-13.67%
|
Dec 31, 2024 | $0.12 B |
150.52%
|
Dec 29, 2023 | $49.73 M |
-39.52%
|
Dec 30, 2022 | $82.23 M |
-96.32%
|
Dec 31, 2021 | $2.23 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() Adaptimmune Therapeutics
ADAP
|
$64.18 M |
-0.000 M
|
![]() UK
|
![]() bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
![]() USA
|
![]() Cellectis
CLLS
|
$0.18 B |
36.593 M
|
![]() France
|
![]() CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
![]() USA
|
![]() Fate Therapeutics
FATE
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() Allogene Therapeutics
ALLO
|
$0.32 B |
0.000 M
|
![]() USA
|
![]() Atara Biotherapeutics
ATRA
|
$35.04 M |
-0.000 M
|
![]() USA
|
Market Cap | = | TIL Stock Price | * | TIL Shares Outstanding |
= | $16.48 | * | 6.53 M | |
= | $0.11 B |